Finally we would like to mention the following institutions for their continuous support to the CNIO.
Servired begun its collaboration with the CNIO in the year 2003, sponsoring a scholarship for a Postdoctoral research work on a project of chromosome alteration characterization and genes implicated in the process of leucemia. Since then they have been renewing the collaboration agreement destined to support part of the Molecular Diagnosis Services of the CNIO.
"A support that will return to us”
There are diverse opposing theories about the social responsibility of the companies and the contribution to the civil society regarding social welfare. The governments, which historically have played a role in Europe, protecting the social welfare in general and public health in particular, can not finance high cost of all the challenges that science and scientists can offer nowadays.
In some cases, the private contribution to the public is absolutely necessary to support medical research. Not only for solidarity or philanthropy reasons, but because everybody will benefit from it, sooner or later, because medical research has a long period of experimentalization and maturity.
The programmes of the Spanish National Cancer Research Centre (CNIO) intend to reduce these periods, prepare research weapons against diseases. That is why ServiRed decided to support with great enthusiasms, with the strong belief that the return will be bigger.
Hewlett Packard is another patron, which from the beginning has made available all its technological resources for the research of cancer. During their first year of collaboration, they donated all the computer equipment of the central office of the Tumours Bank. This has allowed equipping the CNIO with a structure with the capacity to process and store all the data sent by the different hospitals that constitute the network with the necessary agility and reliability.
Recently they have provided the CNIO a new mobile multimedia platform room that contributes to facilitate the scientific discussion within the research groups of our Centre.
"Collaborating with the CNIO entails our company, an important contribution. To support the fight against cancer through research is necessary through the society as well as from private companies. From HP we want to contribute our technology to this great project that we all will benefit."
"The main motive of our support to the CNIO is through the existence of the Lung Cancer Group inside the Molecular Pathology Programme. In fact, the objective of our Foundation is to destine funds to charity institutions that are dedicated to the treatment of people with bronchial or lung cancerous disease without resources. We also make agreements with institutions to grant research scholarships that focus on the diagnosis and treatment of these pathologies. Finally, we offer economic support for psychological attention for terminal ailed and their families."
"The founder of this company passed away due to cancer. Therefore, his children and successors have decided to collaborate with the Centre’s research to avoid similar cases in the future."